Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Shortcomings of an unphysiological triggering of oocyte maturation using human chorionic gonadotropin

Research output: Contribution to journalReviewpeer-review

  1. Association between women's age and stage, morphology, and implantation of the competent blastocyst: a multicenter cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Identification of a unique epigenetic profile in women with diminished ovarian reserve

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Serum ferritin level is inversely related to number of previous pregnancy losses in women with recurrent pregnancy loss

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Proteome of fluid from human ovarian small antral follicles reveals insights in folliculogenesis and oocyte maturation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. N-acetylcysteine protects ovarian follicles from ischemia-reperfusion injury in xenotransplanted human ovarian tissue

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Parental Acceptance Rate of Testicular Tissue Cryopreservation in Danish Boys with Cryptorchidism

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Biological and Clinical Rationale for Androgen Priming in Ovarian Stimulation

    Research output: Contribution to journalReviewpeer-review

View graph of relations

Final maturation of follicles has, in connection with ovarian stimulation and infertility treatment, traditionally been achieved by the administration of a human chorionic gonadotropin (hCG) bolus trigger of 5,000 to 10,000 IU. This trigger serves two purposes: induce oocyte maturation; and serve as luteal phase support owing to its long half-life. It now appears that the hCG bolus trigger is unable to support both these two purposes optimally. In particular, after an hCG trigger, the early luteal phase is hormonally abnormal and different from conditions observed in the natural menstrual cycle: the timing of the initiation of hCG and progesterone rise is much faster after an hCG trigger than in a natural menstrual cycle; the maximal concentrations of hCG and progesterone considerably exceed those naturally observed; and the timing of the peak progesterone concentration after an hCG trigger is advanced several days compared with the natural cycle. Furthermore, the hCG trigger without any follicle-stimulating hormone activity may induce oocyte maturation less efficiently than the combined luteinizing hormone and follicle-stimulating hormone surge normally seen. Collectively, the endometrium is likely to be advanced after an hCG trigger, and the implantation potential is probably not optimal. The precise effect on pregnancy rates after the different progressions of hCG and progesterone concentrations during the early luteal phase has not yet been determined, but more individualized methods using more physiological approaches are likely to improve reproductive outcomes.

Original languageEnglish
JournalFertility and Sterility
Volume114
Issue number2
Pages (from-to)200-208
Number of pages9
ISSN0015-0282
DOIs
Publication statusPublished - Aug 2020

Bibliographical note

Publisher Copyright:
© 2020 American Society for Reproductive Medicine

Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.

    Research areas

  • Early luteal phase, early progesterone rise, endometrial advancement, hCG trigger

ID: 61252792